Literature DB >> 7806518

Solution structure of GRO/melanoma growth stimulatory activity determined by 1H NMR spectroscopy.

K S Kim1, I Clark-Lewis, B D Sykes.   

Abstract

The three-dimensional solution structure of the growth-related protein-alpha/melanoma growth stimulatory activity (GRO/MGSA) has been solved by two-dimensional 1H nuclear magnetic resonance spectroscopy. The GRO/MGSA monomer consists of an NH2-terminal loop, a three-stranded antiparallel beta-sheet, and a COOH-terminal alpha-helix. Dimerization, which is apparent under the experimental conditions used (2 mM, pH 5.10, 30 degrees C), results in a six-stranded antiparallel beta-sheet and a pair of helices with 2-fold symmetry. While the basic fold is similar to that seen for interleukin-8 (IL-8) (Clore, G. M., Appella, E., Yamada, M., Matsushima, K., and Gronenborn, A. M. (1990) Biochemistry, 29, 1689-1696), there are differences in the ELR motif (residues 6-8), the turn involving residues 31-36, which is linked to the NH2-terminal region through the 9-35 disulfide bond. The most significant differences are in the NH2-terminal loop (residues 12-23). In IL-8, all the corresponding regions have been shown to be required for receptor binding (Clark-Lewis, I., Dewald, B., Loetscher, M., Moser, B., and Baggiolini, M. (1994) J. Biol. Chem. 269, 16075-16081). The structural differences thus have been identified between GRO/MGSA and IL-8 could contribute to their different receptor binding specificities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806518

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The solution structure of the anti-HIV chemokine vMIP-II.

Authors:  A C Liwang; Z X Wang; Y Sun; S C Peiper; P J Liwang
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 2.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

3.  Distinct Differences in Structural States of Conserved Histidines in Two Related Proteins: NMR Studies of the Chemokines CXCL1 and CXCL8 in the Free Form and Macromolecular Complexes.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  Biochemistry       Date:  2018-10-02       Impact factor: 3.162

4.  Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.

Authors:  Aishwarya Ravindran; Kirti V Sawant; Jose Sarmiento; Javier Navarro; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

Review 5.  How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways.

Authors:  Krishna Rajarathnam; Michael Schnoor; Ricardo M Richardson; Sudarshan Rajagopal
Journal:  Cell Signal       Date:  2018-11-19       Impact factor: 4.315

6.  CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.

Authors:  Krishna Mohan Sepuru; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

7.  Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.

Authors:  E S Kuloglu; D R McCaslin; M Kitabwalla; C D Pauza; J L Markley; B F Volkman
Journal:  Biochemistry       Date:  2001-10-23       Impact factor: 3.162

8.  Functional characterization of the ELR motif in piscine ELR+CXC-like chemokine.

Authors:  Zhonghua Cai; Chunping Gao; Yong Zhang; Kezhi Xing
Journal:  Mar Biotechnol (NY)       Date:  2008-12-02       Impact factor: 3.619

9.  Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.

Authors:  Krishna Mohan Poluri; Prem Raj B Joseph; Kirti V Sawant; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-07-17       Impact factor: 5.157

10.  Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor.

Authors:  C Dealwis; E J Fernandez; D A Thompson; R J Simon; M A Siani; E Lolis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.